Patient-Reported Outcomes with Durvalumab With or Without Tremelimumab Versus Standard Chemotherapy as First-Line Treatment of Metastatic Non–Small-Cell Lung Cancer (MYSTIC)

Authors: Garon, Edward B., Cho, Byoung Chul, Reinmuth, Niels, Lee, Ki Hyeong, Luft, Alexander, Ahn, Myung-Ju, Robinet, Gilles, Le Moulec, Sylvestre, Natale, Ronald, Schneider, Jeffrey, Shepherd, Frances A., Garassino, Marina Chiara, Geater, Sarayut Lucien, Szekely, Zsolt Papai, Van Ngoc, Tran, Liu, Feng, Scheuring, Urban, Patel, Nikunj, Peters, Solange, Rizvi, Naiyer A.

Source: In Clinical Lung Cancer July 2021 22(4):301-312

Comparison of Volumetric and Linear Serial CT Assessments of Lung Metastases in Renal Cell Carcinoma Patients in a Clinical Phase IIB Study

Authors: Dicken, Volker, Bornemann, Lars, Moltz, Jan Hendrik, Peitgen, Heinz-Otto, Zaim, Souhil, Scheuring, Urban

Source: In Academic Radiology May 2015 22(5):619-625

NEPTUNE: Phase 3 Study of First-Line Durvalumab Plus Tremelimumab in Patients With Metastatic NSCLC.

Authors: de Castro, Gilberto, Rizvi, Naiyer A., Schmid, Peter, Syrigos, Konstantinos, Martin, Claudio, Yamamoto, Nobuyuki, Cheng, Ying, Moiseyenko, Vladimir, Summers, Yvonne, Vynnychenko, Ihor, Lee, Sung Yong, Bryl, Maciej, Zer, Alona, Erman, Mustafa, Timcheva, Constanta, Raja, Rajiv, Naicker, Kirsha, Scheuring, Urban, Walker, Jill, Mann, Helen

Source: Journal of Thoracic Oncology; Jan2023, Vol. 18 Issue 1, p106-119, 14p

Combination therapy comprising diaryl ureas for treating diseases

COMPOSITIONS AND METHODS FOR INHIBITING HIV INFECTIONS BY INHIBITING LEREPO4 AND GLIPR

Combination therapy comprising a diaryl urea compound and a p13, akt kinase or mtor inhibitors (rapamycins) for cancer treatment

BEGONIA: Phase 1b/2, open-label, platform study of the safety and efficacy of durvalumab (D) ± paclitaxel (P) with novel oncology therapies for first-line metastatic triple-negative breast cancer (mTNBC): Addition of arm 7, D + datopotamab deruxtecan (Dato-DXd; DS-1062).

Authors: Schmid, Peter, Nunes, Ana Tablante, Dry, Hannah, Dougherty, Rachel, Karwe, Vatsala, Scheuring, Urban J.

Source: Journal of clinical oncology. 39(15 suppl):TPS1105-TPS1105

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173179612.0x000001&indx=1&recIds=ETOCvdc_100173179612.0x000001

Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia

Authors: Brüggemann, Monika ^*, Raff, Thorsten, Flohr, Thomas, Gökbuget, Nicola, Nakao, Makoto, Droese, Jo, Lüschen, Silke, Pott, Christiane, Ritgen, Matthias, Scheuring, Urban, Horst, Heinz-August, Thiel, Eckhard, Hoelzer, Dieter, Bartram, Claus R., Kneba, Michael

Source: In Blood 1 February 2006 107(3):1116-1123

Early molecular response to posttransplantation imatinib determines outcome in MRD+ Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)

Authors: Wassmann, Barbara, Pfeifer, Heike, Stadler, Michael, Bornhaüser, Martin, Bug, Gesine, Scheuring, Urban J., Brück, Patrick, Stelljes, Matthias, Schwerdtfeger, Rainer, Basara, Nadezda, Perz, Jolanta, Bunjes, Donald, Ledderose, Georg, Mahlberg, Rolf, Binckebanck, Anja, Gschaidmeier, Harald, Hoelzer, Dieter, Ottmann, Oliver G. ^*

Source: In Blood 15 July 2005 106(2):458-463

Early minimal residual disease (MRD) analysis during treatment of Philadelphia chromosome/Bcr-Abl–positive acute lymphoblastic leukemia with the Abl-tyrosine kinase inhibitor imatinib (STI571)

Authors: Scheuring, Urban J. ^*, Pfeifer, Heike, Wassmann, Barbara, Brück, Patrick, Atta, Johannes, Petershofen, Eduard K., Gehrke, Brigitte, Gschaidmeier, Harald, Hoelzer, Dieter, Ottmann, Oliver G.

Source: In Blood 1 January 2003 101(1):85-90

Inhibition of HIV-1 replication by small interfering RNAs directed against Glioma Pathogenesis Related Protein (GliPR) expression

Authors: Ottmann Oliver G, Hoelzer Dieter, Dietrich Ursula, Müller-Kuller Thea, Capalbo Gianni, Scheuring Urban J

Source: Retrovirology, Vol 7, Iss 1, p 26 (2010)

Subject Terms: Immunologic diseases. Allergy, RC581-607

File Description: electronic resource

Relation: http://www.retrovirology.com/content/7/1/26; https://doaj.org/toc/1742-4690

Access URL: https://doaj.org/article/d87ca04938d247e986419efc1d9bd27a

Risk-adapted treatment according to minimal residual disease in adult ALL

Authors: Gökbuget, Nicola, Kneba, Michael, Raff, Thorsten, Bruggemann, Monika, Scheuring, Urban, Reutzel, Regina, Hoelzer, Dieter

Source: In Best Practice & Research Clinical Haematology 2002 15(4):639-652

Proliferative arrest and cell cycle regulation in CD8 +CD28 − versus CD8 +CD28 + T cells

Authors: Scheuring, Urban J, Sabzevari, Helen, Theofilopoulos, Argyrios N

Source: In Human Immunology 2002 63(11):1000-1009

GliPR1 knockdown by RNA interference exerts anti‐glioma effects in vitro and in vivo.

Authors: Scheuring, Urban J., Ritter, Steffi, Martin, Daniel, Schackert, Gabriele, Temme, Achim, Tietze, Stefanie

Source: Journal of Neuro-Oncology; May2021, Vol. 153 Issue 1, p23-32, 10p

Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non–Small Cell Lung Cancer: The MYSTIC Phase 3 Randomized Clinical Trial

Authors: Rizvi, Naiyer A., Cho, Byoung Chul, Reinmuth, Niels, Lee, Ki Hyeong, Luft, Alexander, Ahn, Myung-Ju, van den Heuvel, Michel M., Cobo, Manuel, Vicente, David, Smolin, Alexey, Moiseyenko, Vladimir, Antonia, Scott J., Le Moulec, Sylvestre, Robinet, Gilles, Natale, Ronald, Schneider, Jeffrey, Shepherd, Frances A., Geater, Sarayut Lucien, Garon, Edward B., Kim, Edward S., Goldberg, Sarah B., Nakagawa, Kazuhiko, Raja, Rajiv, Higgs, Brandon W., Boothman, Anne-Marie, Zhao, Luping, Scheuring, Urban, Stockman, Paul K., Chand, Vikram K., Peters, Solange

Source: JAMA Oncology; May 2020, Vol. 6 Issue: 5 p661-674, 14p

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.